Forum Reader
Expert Member
- Joined
- Aug 25, 2019
- Messages
- 1,424
Basically you can't take a look at the positivity rate as an indication if they are only testing certain people again.
That's why you look at both the number of tests and positivity rate.
Basically you can't take a look at the positivity rate as an indication if they are only testing certain people again.
So we ok with Chinese and Russian vaccines? If memory serves me right...all countries mentioned are either going the Chinese or Russian route...
I will certainly not be taking any vaccine produced in Russia or China.
That is exactly the problem, not knowing.Amazing to see people say they won't take these vaccines without knowing the details of their efficacy and study results.
All these vaccines have passed their phase 1 and 2 trials, which means there are no serious side effects and they are all effective at producing an immune response.
Amazing to see people say they won't take these vaccines without knowing the details of their efficacy and study results.
Russia's main vaccine was developed by the Gamaleya Institute and is a combination of adenoviruses that hosts inactivated SARS-CoV-2 virus, that work together to ensure that the immune system creates antibodies and doesn't try to fight the vaccine itself. Efficacy is over 91%, and phase 1, 2, and 3 human trials went fairly well. No serious side effects have been found. A fourth trial of 31,000 participants is underway, but the vaccine is already available under an emergency rollout clause.
Gamaleya is recommending that their Sputnik-V vaccine be supplemented by the Oxford-Zeneca vaccine to cover any potential differences in spike proteins. Argentina has approved it for early use for first-line and healthcare workers. Another Russian-made vaccine, EpiVacCorona, is in phase 3 trials and targets spike proteins.
China has several vaccines in development both internally and outside the country, and in different trial stages. This includes Convidecia (by CanSino Biologics, unknown efficacy but trials will complete soon), BBIBP-CorV (by the Beijing Institute of Biological Products, 86% efficacy), CoronaVac by Sinovac Biotech (efficacy will be determined next month, will be sold to Indonesia and Ukraine), and Sinopharm's inactivated virus vaccine which is currently in phase 3 trials and has reported no serious side effects.
All these vaccines have passed their phase 1 and 2 trials, which means there are no serious side effects and they are all effective at producing an immune response.
Amazing to see people say they won't take these vaccines without knowing the details of their efficacy and study results.
Russia's main vaccine was developed by the Gamaleya Institute and is a combination of adenoviruses that hosts inactivated SARS-CoV-2 virus, that work together to ensure that the immune system creates antibodies and doesn't try to fight the vaccine itself. Efficacy is over 91%, and phase 1, 2, and 3 human trials went fairly well. No serious side effects have been found. A fourth trial of 31,000 participants is underway, but the vaccine is already available under an emergency rollout clause.
Gamaleya is recommending that their Sputnik-V vaccine be supplemented by the Oxford-Zeneca vaccine to cover any potential differences in spike proteins. Argentina has approved it for early use for first-line and healthcare workers. Another Russian-made vaccine, EpiVacCorona, is in phase 3 trials and targets spike proteins.
China has several vaccines in development both internally and outside the country, and in different trial stages. This includes Convidecia (by CanSino Biologics, unknown efficacy but trials will complete soon), BBIBP-CorV (by the Beijing Institute of Biological Products, 86% efficacy), CoronaVac by Sinovac Biotech (efficacy will be determined next month, will be sold to Indonesia and Ukraine), and Sinopharm's inactivated virus vaccine which is currently in phase 3 trials and has reported no serious side effects.
All these vaccines have passed their phase 1 and 2 trials, which means there are no serious side effects and they are all effective at producing an immune response.
2 hours ago (07:39 GMT)Amazing to see people say they won't take these vaccines without knowing the details of their efficacy and study results.
Russia's main vaccine was developed by the Gamaleya Institute and is a combination of adenoviruses that hosts inactivated SARS-CoV-2 virus, that work together to ensure that the immune system creates antibodies and doesn't try to fight the vaccine itself. Efficacy is over 91%, and phase 1, 2, and 3 human trials went fairly well. No serious side effects have been found. A fourth trial of 31,000 participants is underway, but the vaccine is already available under an emergency rollout clause.
Gamaleya is recommending that their Sputnik-V vaccine be supplemented by the Oxford-Zeneca vaccine to cover any potential differences in spike proteins. Argentina has approved it for early use for first-line and healthcare workers. Another Russian-made vaccine, EpiVacCorona, is in phase 3 trials and targets spike proteins.
China has several vaccines in development both internally and outside the country, and in different trial stages. This includes Convidecia (by CanSino Biologics, unknown efficacy but trials will complete soon), BBIBP-CorV (by the Beijing Institute of Biological Products, 86% efficacy), CoronaVac by Sinovac Biotech (efficacy will be determined next month, will be sold to Indonesia and Ukraine), and Sinopharm's inactivated virus vaccine which is currently in phase 3 trials and has reported no serious side effects.
All these vaccines have passed their phase 1 and 2 trials, which means there are no serious side effects and they are all effective at producing an immune response.
They might be even better than, pfizer, but how can anyone trust anything coming from Russian and Chinese governments?
www.wam.ae
$128 million (approx R2 billion) to cover 10% of the population.Does anyone remembers what SA needed to pay for the vaccines for 3-10% of the population? AZ vaccine comes to around R50 a shot, and I have the feeling we will be paying ridiculously inflated prices.
so around R300 per person$128 million (approx R2 billion) to cover 10% of the population.
The 15% down payment which has caused so much noise was $19.2 million.
Looking more and more like Tiffany Dover, the hot Stateside nurse who fainted on live TV after recieving the 'vaccine', is now dead.
Aspen will be manufacturing locally on behalf of Janssen / Johnson and JohnsonI believe they are looking at it - wasn’t minister of health quoted as saying we have manufacturing capabilities here too?
honestly I think COVAX is also a bit of a “we better do this to look like we’re supporting WHO and playing well with the others” move. There are other plans in progress in govt and private sector and a combo of the two.
...and will take them a year to start production lineAspen will be manufacturing locally on behalf of Janssen / Johnson and Johnson
I believe they already have the production line. But only for "normal" vaccines not the fancy Pfizer/Moderna ones. So the Oxford one I believe (stand corrected) we could produce here?...and will take them a year to start production line
I think the Johnson & Johnson one may be better in that it is a single dose.Ok thanks for the information - I thought given the proximity to the US - the storage requirements not withstanding - they would be administering the Pfizer and Moderna vaccines. I will certainly not be taking any vaccine produced in Russia or China.
The Oxford vaccine looks most promising for us in SA in terms of cost and storage requirements.
They will be using their existing facility in Port Elizabeth...and will take them a year to start production line
There are people who had bad side effects from Polio vaccines too. Should we re-introduce Polio and stop vaccinations? There's always a small % of risk in any vaccine. It should not excuse the 99% who will benefit from it. Also, people have a choice not to accept it if they feel the vaccine poses a higher risk than COVID-19, but lets not Karen-ize what is a very good vaccine considering the time it took to make it.As is this Israeli / Swiss victim.
Do not take this vaccine.Zerohedge
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zerowww.zerohedge.com
Yes, in some news article it said will take them a year to start production.J&J tried with single dose and it seems that they didn't like the results much , so Dec they started a new trial in USA with double dose ... if I remember correctly.They will be using their existing facility in Port Elizabeth